Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06518148

Causes of Visual Impairment Among Patients Applying for the Visually Disability Certification

Causes of Visual Impairment Among Patients Applying for the Visually Disability Certification in Upper Egypt: A Retrospective Study

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
2,000 (actual)
Sponsor
New Valley University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Causes of Visual Impairment Among Patients Applying for the Visually Disability Certification in Upper Egypt: A Retrospective Study

Detailed description

There are at least 2.2 billion individuals with near- or far-sightedness worldwide. Nearly half of these cases-at At least 1 billion-have untreated vision impairment that may have been avoided. The leading cause of blindness or impaired distant vision among these 1 billion people is diabetic retinopathy (3.9 million), age-related macular degeneration (8 million), cataracts (94 million), refractive error (88.4 million), and glaucoma (7.7 million). Presbyopia (826 million) is the primary ailment that impairs close vision. According to estimates, there are four times as many cases of distant vision impairment in low- and middle-income areas as there are in high-income areas. Aging populations and population expansion are predicted to raise the likelihood that more people may have visual impairment. Early on, irreversible severe visual impairment in young children can lead to delayed motor, verbal, emotional, social, and cognitive development, which can have long-term effects. Children of school age who are visually impaired may also perform less academically. The quality of life is significantly impacted by vision impairment in adult populations. Adults who are visually impaired may have greater rates of anxiety and depression as well as decreased employment rates. Vision impairment in older persons can increase their risk of falling and breaking bones, walking difficulties, social isolation, and early admission into nursing homes or other care facilities. According to estimates, vision impairment costs the world's economy $411 billion annually in lost productivity (purchasing power parity) . This amount is greatly above the predicted $25 billion cost gap incurred from treating vision impairment. This study is to demonstrate the causes of visual impairment in upper Egypt among the different age groups and evaluate the possibility of preventing these disorders

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST1- uncorrected and best corrected visual acuity (UCVA and BCVA) by Snellen's-chart.2-slit lamp bio microscopy (Haag-Streit, USA).3-IOP measurements (Goldmann Applanation tonometer)diagnostic test;UCVA, IOP, Electrophysiological study

Timeline

Start date
2024-04-20
Primary completion
2025-12-20
Completion
2025-12-20
First posted
2024-07-24
Last updated
2025-09-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06518148. Inclusion in this directory is not an endorsement.